ACP Comment Letter to the House Energy and Commerce Committee on Drug Shortages

ACP applauds the consideration of policies that would improve market conditions for generic drugs and urges Congress to address the rising costs of prescription drugs and its impact on patient care.

Robin Chichester

drug shortages; patient access; Medicare Physician Fee Schedule; Medicare Part B; S. 652; H.R.2630; The Safe Step Act of 2023; step therapy; nonmedical drug switching; patient access; pharmaceuticals; medicine shortage; rising healthcare costs; patient care; generic prescription drugs; generic drugs; prescription drugs; payment models; medication non-adherence; medication switching

Thu, 08/24/2023 - 9:29 AM EDT

Thu, 08/24/2023 - 2:43 PM EDT

2

acp_comment_letter_to_house_energy_and_commerce_committee_on_drug_shortages_2023.pdf

{"Author":"Robin Chichester","CreationDate":"2023-08-24T09:29:15-04:00","Creator":"Microsoft\u00ae Word for Microsoft 365","Keywords":"drug shortages; patient access; Medicare Physician Fee Schedule; Medicare Part B; S. 652; H.R.2630; The Safe Step Act of 2023; step therapy; nonmedical drug switching; patient access; pharmaceuticals; medicine shortage; rising healthcare costs; patient care; generic prescription drugs; generic drugs; prescription drugs; payment models; medication non-adherence; medication switching","ModDate":"2023-08-24T14:43:22-04:00","Producer":"Microsoft\u00ae Word for Microsoft 365","Title":"ACP Comment Letter to the House Energy and Commerce Committee on Drug Shortages","Pages":2,"pdf:producer":"Microsoft\u00ae Word for Microsoft 365","pdf:keywords":"drug shortages; patient access; Medicare Physician Fee Schedule; Medicare Part B; S. 652; H.R.2630; The Safe Step Act of 2023; step therapy; nonmedical drug switching; patient access; pharmaceuticals; medicine shortage; rising healthcare costs; patient care; generic prescription drugs; generic drugs; prescription drugs; payment models; medication non-adherence; medication switching","dc:format":"application\/pdf","dc:creator":"Robin Chichester","dc:title":"ACP Comment Letter to the House Energy and Commerce Committee on Drug Shortages","dc:subject":["drug shortages","patient access","Medicare Physician Fee Schedule","Medicare Part B","S. 652","H.R.2630","The Safe Step Act of 2023","step therapy","nonmedical drug switching","patient access","pharmaceuticals","medicine shortage","rising healthcare costs","patient care","generic prescription drugs","generic drugs","prescription drugs","payment models","medication non-adherence","medication switching"],"xmp:creatortool":"Microsoft\u00ae Word for Microsoft 365","xmp:createdate":"2023-08-24T09:29:15-04:00","xmp:modifydate":"2023-08-24T14:43:22-04:00","xmp:metadatadate":"2023-08-24T14:43:22-04:00","xmpmm:documentid":"uuid:0AA03713-38A2-4359-A72B-A913B4E99A6A","xmpmm:instanceid":"uuid:484c5aca-c815-42f4-983f-db80f0312c4c"}

2023